Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rutgers

Showing results (931-940 of 982) with videos related to

Pageof 99
Sort By:
The Lancet. Oncology|November 29, 2007
Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER)Jolien M Bueno-de-Mesquita, Wim H van Harten, Valesca P Retel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2020
Standard Anthracycline Based Versus Docetaxel-Capecitabine in Early High Clinical and/or Genomic Risk Breast Cancer in the EORTC 10041/BIG 3-04 MINDACT Phase III TrialSuzette Delaloge, Martine Piccart, Emiel Rutgers, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 24, 2015
Does rapid genetic counseling and testing in newly diagnosed breast cancer patients cause additional psychosocial distress? results from a randomized clinical trialMarijke R Wevers, Margreet G E M Ausems, Senno Verhoef, et al.
Iscience|August 29, 2024
Predictive gene expression profile for adjuvant taxane benefit in breast cancer in the MATADOR trialMark Opdam, Annelot G J van Rossum, Marlous Hoogstraat, et al.
International Journal of Molecular Sciences|October 27, 2022
Longitudinal Serum Protein Analysis of Women with a High Risk of Developing Breast Cancer Reveals Large Interpatient Versus Small Intrapatient Variations: First Results from the TESTBREAST StudySophie C Hagenaars, Lennard J M Dekker, Bob Ravesteijn, et al.
The Lancet. Oncology|June 22, 2019
MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trialSepideh Saadatmand, H Amarens Geuzinge, Emiel J T Rutgers, et al.
The Science of the Total Environment|June 13, 2020
Effects of Dutch livestock production on human health and the environmentPim M Post, Lenny Hogerwerf, Eddie A M Bokkers, et al.
JAMA Oncology|July 31, 2020
Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial RiskH Amarens Geuzinge, Inge-Marie Obdeijn, Emiel J T Rutgers, et al.
Biological Reviews of the Cambridge Philosophical Society|November 16, 2019
Towards an integrative understanding of soil biodiversityMadhav P Thakur, Helen R P Phillips, Ulrich Brose, et al.
The Lancet. Oncology|March 15, 2021
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by ageMartine Piccart, Laura J van 't Veer, Coralie Poncet, et al.
Pageof 99

Showing results (931-940 of 982) with videos related to

Sort By:
Pageof 99
The Lancet. Oncology|November 29, 2007
Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER)Jolien M Bueno-de-Mesquita, Wim H van Harten, Valesca P Retel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2020
Standard Anthracycline Based Versus Docetaxel-Capecitabine in Early High Clinical and/or Genomic Risk Breast Cancer in the EORTC 10041/BIG 3-04 MINDACT Phase III TrialSuzette Delaloge, Martine Piccart, Emiel Rutgers, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 24, 2015
Does rapid genetic counseling and testing in newly diagnosed breast cancer patients cause additional psychosocial distress? results from a randomized clinical trialMarijke R Wevers, Margreet G E M Ausems, Senno Verhoef, et al.
Iscience|August 29, 2024
Predictive gene expression profile for adjuvant taxane benefit in breast cancer in the MATADOR trialMark Opdam, Annelot G J van Rossum, Marlous Hoogstraat, et al.
International Journal of Molecular Sciences|October 27, 2022
Longitudinal Serum Protein Analysis of Women with a High Risk of Developing Breast Cancer Reveals Large Interpatient Versus Small Intrapatient Variations: First Results from the TESTBREAST StudySophie C Hagenaars, Lennard J M Dekker, Bob Ravesteijn, et al.
The Lancet. Oncology|June 22, 2019
MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trialSepideh Saadatmand, H Amarens Geuzinge, Emiel J T Rutgers, et al.
The Science of the Total Environment|June 13, 2020
Effects of Dutch livestock production on human health and the environmentPim M Post, Lenny Hogerwerf, Eddie A M Bokkers, et al.
JAMA Oncology|July 31, 2020
Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial RiskH Amarens Geuzinge, Inge-Marie Obdeijn, Emiel J T Rutgers, et al.
Biological Reviews of the Cambridge Philosophical Society|November 16, 2019
Towards an integrative understanding of soil biodiversityMadhav P Thakur, Helen R P Phillips, Ulrich Brose, et al.
The Lancet. Oncology|March 15, 2021
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by ageMartine Piccart, Laura J van 't Veer, Coralie Poncet, et al.
Pageof 99